BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the sale ...
Everything you need from Yeti (with just a few exceptions) is on sale, and we've pulled together your gifting shopping list ...
Third Quarter 2024 Net Revenues of $2.9 Million, Gross Profit of $2.2 Million and Gross Margin of 75% 2024 Net Revenue of $19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback